Discover how curing Hepatitis C with DAAs revolutionizes kidney transplantation, allowing safe use of HCV-positive donor organs with excellent long-term outcomes.
Discover how modern Direct-Acting Antivirals achieve over 95% cure rates for acute Hepatitis C in just 8-12 weeks, revolutionizing treatment outcomes.
Exploring HCV exposure among healthcare workers in rural Lower Egypt - prevalence, risk factors, and Egypt's remarkable elimination efforts
Explore the epidemiology, discovery, and prevention of Hepatitis C - a bloodborne virus affecting millions worldwide and the Nobel Prize-winning breakthrough that made it curable.
Discover how individual immune systems mount unique responses to Hepatitis C virus, revealing personalized antibody kinetics and implications for vaccine development.
Explore the epidemiology of Hepatitis C - how this silent virus spreads, who it affects, and the scientific breakthroughs that helped us understand and combat this global health challenge.
A groundbreaking seroepidemiologic survey of 21,000 US troops reveals the prevalence and incidence of Hepatitis C virus infection within the military population.